Bill

Bill > HB1344


CO HB1344

CO HB1344
FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use


summary

Introduced
03/28/2022
In Committee
04/27/2022
Crossed Over
05/31/2022
Passed
05/31/2022
Dead
Signed/Enacted/Adopted
06/08/2022

Introduced Session

2022 Regular Session

Bill Summary

CONCERNING THE LAWFUL USE OF A PRESCRIPTION DRUG THAT CONTAINS 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) THAT IS APPROVED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION.

AI Summary

This bill aims to allow the lawful use of a prescription drug that contains 3,4-Methylenedioxymethamphetamine (MDMA), which is approved by the United States Food and Drug Administration (FDA). The bill cites the potential benefits of MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD) and other comorbidities, particularly among vulnerable populations like veterans, first responders, and survivors of trauma. The bill would remove MDMA from Schedule I of the Controlled Substances Act when it is approved by the FDA for prescription use, allowing it to be used by authorized medical professionals in Colorado under the same federal regulations as other FDA-approved prescription drugs.

Committee Categories

Health and Social Services

Sponsors (33)

Last Action

Governor Signed (on 06/08/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...